I lost three stone in just 10 weeks on Mounjaro, but suffered with an instant side effect that won't budge
NO WEIGH I lost three stone in just 10 weeks on Mounjaro, but suffered with an instant side effect that won't budge
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A WOMAN has revealed that she has lost three stone in just ten weeks thanks to weight loss jabs.
Kayleigh Akister, from Lancaster, took to social media to share her weight loss transformation.
Sign up for Scottish Sun
newsletter
Sign up
2
Kayleigh Akister revealed her weigh tloss journey using Mounjaro
Credit: Facebook
2
Despite being thrilled with her new weight, there was one side effect she couldn't budge
Credit: Facebook
She wrote: "After 10 weeks I have lost 3 stone."
Taking to social media, she shared images of herself before her weight loss wearing a beige floor-length dress.
She revealed that she initially weighed 14.5st and had gone down to 11.5st.
But now, Kayleigh looked much smaller and happier as she wore a silky, figure-hugging dress that showed off her new body.
While Kayleigh was thrilled by the weight loss, she had experienced one setback.
She revealed that since being on the weight loss jab, her hair had become thin and was falling out.
Kayleigh added: "But (I) started with hair loss, it feels so thin anyone else have this and what will help please?"
Unfortunately, hair loss is listed as a common side effect of Mounjaro.
This can be heightened with losing weight at a fast pace.
Telogen effluvium is a form of alopecia that is temporary and caused by sudden changes in the body (like weight loss).
I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care
It causes hair follicles to enter the resting phase and shedding phase of the hair growth cycle.
Kayleigh's post was shared to the Facebook group, mounjaro ozempic wegovy weight loss support, and people were quick to share their tips on combatting hair loss on the drug.
One person wrote: "Congrats on your success!! Hair loss is common with weight loss, especially a lot of weight loss in a short time. Make sure you're getting your protein, drinking water and taking a multivitamin."
Another commented: "My hair is so bad. I don't know how I'm not bald already! I'm doing everything I can to stop the shed but nothing seems to be working!"
"You look amazing. I believe losing weight too quickly will cause some hair loss," penned a third.
Meanwhile, a fourth said: "I take collagen and biotin and it definitely helps me."
"Try taking collagen supplements, they've really strengthened my hair and nails! My skin looks younger too. Been on them 2 months,' claimed a fifth
Someone else added: "Bloody hell, well done. 16 weeks and a whopping 1 stone down."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Thousands of patients miss out on weight loss jab due to NHS ‘postcode lottery'
Thousands of obese patients are missing out on a key weight loss jab due to a 'postcode lottery' of provision in the NHS, according to a report. Mounjaro, dubbed the 'King Kong' of weight loss medicine, was supposed to be available through GP surgeries from 23 June under an agreement between NHS England and NICE. But just eight out of 42 NHS Integrated Care Boards (ICBs) in England were able to provide treatment to patients, according to Sky News, who obtained the data using a Freedom of Information request. Many other ICBs were reportedly unable to confirm when treatment would be available. Dr Jonathan Hazlehurst, an endocrinologist and obesity physician at University Hospitals Birmingham, said patients were 'set up for failure' and have been treated unfairly. "Giving people open promises and setting them up for disappointment and failure is clearly grossly unfair. That's what the current system is doing,' he told the broadcaster. NICE said in December that the NHS should offer Mounjaro to patients with a BMI of over 40 and at least four clinical conditions related to their weight, such as heart disease or type 2 diabetes. It calculated from NHS England data that there were 97,500 patients who should be treated in the first year. But Dr Hazlehurst claims NHS England has only provided funding for just over 22,000 patients. The Independent has approached NHS England for comment. A spokesperson told Sky News that NHS England had "fully supported the rollout" of Mounjaro. "We issued guidance and provided funding in March to all Integrated Care Boards to support treatment costs, enable scaling of services and provide wrap-around care, including digital support services,' they said. It comes after NICE warned many individuals might regain weight if not adequately supported after ceasing treatment. It stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance applies to individuals receiving these treatments through the NHS. However, an estimated 1.5 million people in the UK are currently using weight-loss injections, with the vast majority paying privately. These individuals will not be eligible for NHS support once their treatment concludes. The new 'quality standard' from NICE says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made.'
Sky News
2 hours ago
- Sky News
Ozempic to Mounjaro - what are the weight loss injections and what were they designed to do?
Drugs designed to treat diabetes and repurposed as miracle diet aids have taken over TikTok - and Hollywood. The weight loss caused by these weekly injectables is rapid and previously unattainable, people boast, showing off newly svelte bodies. But what are these drugs, how do they work - and what were they originally designed to do? Ozempic, Wegovy, Mounjaro - what are they? Let's start with the most well-known of the trio: Ozempic. Ozempic blew up in 2022 - if media reports from the US were to be believed, every pound dropped in LA was probably thanks to the "miracle" injectable drug. What started as the preserve of A-listers and the Hollywood elite quickly grew in popularity. The drug's generic name is semaglutide. This is the same as Wegovy, which has been licensed as a weight loss drug in the UK and is now available on the NHS. Wegovy has a slightly higher dosage and is designed for weight loss, while Ozempic's primary purpose was as a diabetes treatment (more on that later). Mounjaro - also known by its generic name tirzepatide - is the newer kid on the block. Like Ozempic and Wegovy, it suppresses the appetite and lengthens the amount of time food stays in the stomach, leading to weight loss - at least for as long as you carry on taking it. In 2022, the US Food and Drink Administration (FDA) fast-tracked approval of the drug to treat obesity after a study showed it helped people lose more than 20% of their bodyweight. Mounjaro was supposed to be available through GP surgeries and other community services in the UK from 23 June. But at the start of August, Sky News research revealed only eight of 42 NHS Integrated Care Boards (ICBs) in England had started providing treatment to patients, and many of the rest unable to guarantee when it would be available. 3:31 From diabetes drug to diet pill Ozempic and Mounjaro were both developed as treatments for type 2 diabetes. The drugs, which come as weekly injections, lower blood sugar by increasing insulin production when your blood sugar is rising and helping prevent your liver making and releasing too much sugar. So how do they cause weight loss? Both semaglutide and tirzepatide work by mimicking the hormone, GLP-1 (glucagon-like peptide one), to manage hunger and slow down digestion. Tirzepatide - Mounjaro - is a dual-acting drug and also mimics the hormone GIP (glucose-dependent insulinotropic polypeptide). In terms of weight loss, in clinical trials people lost up to 20% of their body weight on tirzepatide and 15% on semaglutide. Researchers have also found the weight loss jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose. They sound like miracle drugs for people wanting to lose weight - what's the catch? There are a few downsides. First off, the listed side effects: nausea, vomiting and diarrhoea, bad enough for about 5% of people in the semaglutide trial to stop taking it and 6-7% in the tirzepatide trial. People in the semaglutide trial also experienced problems with gallstones. The drugs also carry serious risks including kidney failure, pancreatitis and thyroid cancer. Another downside has been dubbed "Ozempic face". Facial ageing is a side effect of sudden weight loss as people find the skin on their face sagging where once it was plump. The drugs also only work for as long as you carry on taking them, and people have reported gaining back all the weight they lost after stopping the drug - either out of choice or because of a supply shortage. In August, the National Institute for Health and Care Excellence (NICE) - the body that provides guidance on the use of new drugs - said that people coming off the drugs should be offered "structured advice and follow-up support" to help prevent weight gain. This includes being monitored by the NHS for at least a year after completing treatment and support to help build "long-term behavioural habits, use self-monitoring tools, and draw on wider support - from online communities to family-led interventions and local activities". Shortages for diabetics Perhaps a bigger conversation than side effects for individuals is around the impact on people who rely on these treatments, now they've exploded in popularity as a weight loss quick-fix. While intended for diabetics, Ozempic and Mounjaro are prescribed "off-label" in the US to people wanting to shed weight. The drugs faced widespread shortage last year, with reports of diabetics having to drive from pharmacy to pharmacy in search of stock because of the high demand. Links to cancer prevention Research has suggested weight loss jabs, officially GLP-1 receptor agonists, could almost halve the risk of obesity-related cancers. The study, published in the journal eClinicalMedicine, was presented at the European Congress on Obesity in Malaga. It found that there were similar rates of obesity -related cancer among patients treated with the injections and those given weight loss, or bariatric, surgery. Dr Yael Wolff Sagy, the study's co-lead author from Clalit Health Services in Tel-Aviv, Israel, said a "direct effect" of the injections was that they were found "to be 41% more effective at preventing obesity-related cancer". "We do not yet fully understand how GLP-1s work," she said. "But this study adds to the growing evidence showing that weight loss alone cannot completely account for the metabolic, anti-cancer, and many other benefits that these medications provide." Co-lead Professor Dror Dicker, from Hasharon Hospital, Rabin Medical Centre in Israel, suggested the protective effects of the drugs "likely arise from multiple mechanisms, including reducing inflammation". He added further research was needed "to make sure that these drugs do not increase the risk for non-obesity-related cancers". Being overweight or obese is the second biggest cause of cancer in the UK, causing more than one in 20 cancer cases, according to the NHS. Are they available in the UK? An estimated 1.5 million people are taking weight loss jabs in the UK, the vast majority of whom pay for them privately. Ozempic is available in the UK for type 2 diabetes patients with a prescription. Wegovy and Mounjaro is available to NHS patients, but only through specialist weight management services. Over the next three years, around 240,000 people with the "greatest need" are expected to receive Mounjaro through the NHS. However, Sky News research into Wegovy and Mounjaro shows delays in the rollout of both weight loss jabs.
Scottish Sun
2 hours ago
- Scottish Sun
I blamed coffee on an empty stomach for my puffy ‘moon face' and belly fat but I was living with cancer at 21
'People tell me to stop scrolling but I'm just like sorry, TikTok did save my life,' the young woman says TRUE TWIST I blamed coffee on an empty stomach for my puffy 'moon face' and belly fat but I was living with cancer at 21 Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) AT first, Cleo Lambert blamed her puffy 'moon face' and belly fat on coffee, but the real cause was a deadly tumour growing inside her stomach. The 21-year-old, from Tring in Hertfordshire, claimed a TikTok video saved her life after it led to the discovery of the 17cm cancerous mass. Sign up for Scottish Sun newsletter Sign up 10 Cleo Lambert says a TikTok video helped her get a timely cancer diagnosis Credit: Kennedy Newsand Media 10 The 21-year-old blamed her puffy 'moon face' and belly fat on coffee 10 After several visits to her GP, Cleo was diagnosed with polycystic ovary syndrome "I had every single one of the symptoms and I thought it was so weird,' Cleo said. 'I Googled that and instantly I was like 'I've got this'.' She had been experiencing symptoms since 2022, including bloating, weight gain, a puffy face, and facial hair, but said she 'struggled to piece them together.' After several visits to her GP, Cleo was diagnosed with polycystic ovary syndrome (PCOS) in 2023. She tried managing the symptoms with diet and lifestyle changes, even cutting out coffee, which she blamed for her puffy face. But despite her efforts, her symptoms worsened. Cleo said the changes to her body left her so self-conscious she 'didn't want to leave the house' or socialise. Then, last summer, while scrolling on TikTok, Cleo came across a video of someone describing the exact symptoms she had. Reading the comments, someone suggested it could be Cushing's syndrome, a hormonal disorder caused by excess cortisol. 'It said it was a benign tumour so I thought right OK, I've got a tumour but it's not cancer so it will be fine,' Cleo said. The major symptoms of 'common cancer' as HSE say 'know the signs' She booked an appointment with her GP and went through blood tests and other scans. An MRI later revealed a 17cm tumour in her right abdomen. The diagnosis was devastating: stage four adrenal cortical cancer, a rare and aggressive cancer of the adrenal gland. Cleo had surgery to remove the tumour on August 30, 2024, and has since undergone six months of chemotherapy. 'I've got a few little spots [of cancer] left but they're going to rescan it at the start of September and see what's going on,' she said. 'I've got two years of the chemo tablets which would end in December 2027 but it's obviously changing all the time. 10 Then a video suggested her symptoms could be Cushing's syndrome Credit: Kennedy Newsand Media 10 An x-ray revealed the tumour growing on the right side of her abdomen Credit: Kennedy Newsand Media 10 Cleo was diagnosed with stage four adrenal cortical cancer, a rare and aggressive cancer of the adrenal gland Credit: Kennedy Newsand Media 10 The student has undergone six months of chemotherapy since 'It might change next month, it might change next week. I've got scans every three months. "Doctors have said they might end up doing radiotherapy or another surgery. "They just keep discussing it all the time. Right now it's so small that it's not harming me.' Cleo, who hopes to study fashion buying and merchandising at university, says the TikTok video saved her life. 'The first doctor I saw said that if I hadn't seen that TikTok and gone to him with that list of symptoms then it could have taken an extra year to diagnose me,' she said. 'If I'd waited another year then I would not be here because it [the tumour] was so big and it was growing into all of my other organs. 'TikTok literally saved my life. That's what I always say to my friends. 'People tell me to stop scrolling but I'm just like sorry, TikTok did save my life. 'If I didn't go to the doctors after seeing that video I would not be alive.' 10 Cleo now claims the TikTok video saved her life 10 'People tell me to stop scrolling but I'm just like sorry, TikTok did save my life,' she says 10 She still has two years of chemotherapy tablets to complete Credit: Kennedy Newsand Media
